Chimeric Antigen Receptor-induced Antigen Loss Protects CD5.CART Cells from Fratricide Without Compromising On-target Cytotoxicity
Overview
General Medicine
Authors
Affiliations
Chimeric antigen receptor T cells (CART) targeting lymphocyte antigens can induce T cell fratricide and require additional engineering to mitigate self-damage. We demonstrate that the expression of a chimeric antigen receptor (CAR) targeting CD5, a prominent pan-T cell antigen, induces rapid internalization and complete loss of the CD5 protein on T cells, protecting them from self-targeting. Notably, exposure of healthy and malignant T cells to CD5.CART cells induces similar internalization of CD5 on target cells, transiently shielding them from cytotoxicity. However, this protection is short-lived, as sustained activity of CD5.CART cells in patients with T cell malignancies results in full ablation of CD5 T cells while sparing healthy T cells naturally lacking CD5. These results indicate that continuous downmodulation of the target antigen in CD5.CART cells produces effective fratricide resistance without undermining their on-target cytotoxicity.
Maciocia N, Maciocia N, Wade B, Wade B, Maciocia P, Maciocia P Blood Adv. 2024; 9(4):913-923.
PMID: 39715467 PMC: 11876835. DOI: 10.1182/bloodadvances.2023012263.
Trogocytosis in CAR immune cell therapy: a key mechanism of tumor immune escape.
Chen Y, Xin Q, Zhu M, Qiu J, Qiu J, Li R Cell Commun Signal. 2024; 22(1):521.
PMID: 39468646 PMC: 11514842. DOI: 10.1186/s12964-024-01894-2.
Mishra H, Kalyuzhny A Cells. 2024; 13(18.
PMID: 39329700 PMC: 11430090. DOI: 10.3390/cells13181516.